Science
Mechanism of Action
This extract acts as a comprehensive skin-calming agent, significantly reducing irritation and alleviating itchiness. Its mechanism involves potent antioxidant activity, shielding the skin from free radical damage, including environmental stressors like sun exposure. It exhibits broad-spectrum antimicrobial efficacy, targeting both odor-causing and acne-propagating bacteria, such as Propionibacterium acnes. Furthermore, Mahonia Aquifolium Root Extract possesses robust anti-inflammatory properties, achieved by suppressing inflammatory cytokines and inhibiting T-cell infiltration, which is crucial for conditions like psoriasis and atopic dermatitis. It also demonstrates an antiproliferative effect on human keratinocytes, modulating excessive skin cell growth. The primary bioactive components are a suite of alkaloids, with berberine being the most notable, complemented by oxyberberine, corytuberine, columbamine, and jatrorrhizine, which contribute to its therapeutic profile via mechanisms such as lipoxygenase inhibition.
Research
Clinical Evidence
High confidence10%
Transparency
Dusting Analysis
While topical Mahonia aquifolium extract has demonstrated significant clinical efficacy for conditions like psoriasis at concentrations of 10%, typical cosmetic usage levels are considerably lower, generally ranging from 0.1% to 1%. This substantial difference suggests that many general cosmetic formulations may not include the extract at concentrations proven to deliver its full therapeutic benefits, potentially leading to 'dusting' where it's included for marketing claims rather than robust efficacy.
The Formula
Formulation
Stability
Extracts are optimally prepared in polar solvent systems, such as aqueous or water/vegetable glycerin blends (e.g., 40% purified water and 60% vegetable glycerin), ensuring good dispersibility. For optimal potency and stability, store in a cool, dark, and dry environment, where it can maintain efficacy for up to 4 years.
Conflicts
- Due to the presence of berberine, a constituent that can act as a weak photosensitizer in water, formulations containing Mahonia aquifolium root extract should avoid direct sunlight or artificial UVA exposure to prevent potential phototoxicity.
Safety
Safety Profile
A formal Cosmetic Ingredient Review (CIR) safety assessment is pending, categorizing the ingredient as 'Insufficient Data or Information' with a recommendation for further action if its use continues. Despite this, studies on compromised human skin indicate good tolerability, with a very low risk of sensitization; less than 1% of individuals reported minor reactions like burning or rash. While topical use is generally considered safe within typical cosmetic usage levels (0.1% to 1%), oral consumption is advised against, particularly for pregnant individuals and those with severe liver or kidney conditions, due to potential side effects associated with its berberine content. Additionally, berberine's potential as a weak photosensitizer necessitates caution with sun or artificial UVA exposure when incorporated topically.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Mahonia Aquifolium Root Extract is a valuable active for targeted skincare, exhibiting clinically proven efficacy in reducing psoriasis symptoms and demonstrating broad antimicrobial and anti-inflammatory benefits, though its CIR safety status remains 'insufficient data' and formulations require careful consideration of photosensitization risk.
Related
Similar Ingredients
Finding similar ingredients…